Navigation Links
Asthma and Allergy Foundation of America Challenges Patients and Caregivers to 'Get Smart About Asthma'
Date:1/24/2013

WASHINGTON, Jan 24, 2013 /PRNewswire/ -- The Asthma and Allergy Foundation of America (AAFA) and Teva Respiratory announced today the launch of Get Smart About Asthma, a comprehensive online asthma management resource that takes a unique look at the underlying cause of asthma – inflammation. The website – www.GetSmartAboutAsthma.com – aims to increase understanding of how inflammation in both the large and small airways plays an important role in asthma persistence or severity, in addition to providing tools and educational resources to help minimize and manage the symptoms associated with persistent asthma. Designed for the well-informed asthma patient or caregiver, the website features important information about the latest research in asthma. The site also provides downloadable toolkits and discussion guides to help people with asthma maintain open lines of communication with their healthcare providers. 

"Many of the 25 million Americans who suffer from asthma may know the basics about their condition, but GetSmartAboutAsthma.com will expand their knowledge even more," said Dr. LeRoy Graham , pediatric pulmonologist at Georgia Pediatric Pulmonology Associates. "Asthma is a life-long condition that, if not managed properly, can also be life-threatening. It is important for patients to have a thorough understanding about their asthma, including how to manage chronic inflammation on a daily basis."

People with persistent asthma can develop ongoing inflammation in the large and small airways of the lungs. Asthma symptoms due to inflammation can be different depending on the severity, but common symptoms can include coughing, wheezing, trouble breathing and tightness in the chest. Despite chronic inflammation of the airways, people with persistent asthma may not always experience these outward symptoms of asthma. For these patients, current treatment guidelines recommend a daily maintenance therapy to help prevent inflammation, manage symptoms and control asthma. When asthma is under control, patients lessen the chance of an asthma attack and can remain active without having asthma symptoms and worry less about emergency visits or stays at the hospital.

"Having worked for close to 60 years with patients living with asthma, AAFA understands how important it is for them to take a proactive approach to fully educating themselves about their condition and the proper ways to effectively manage and control their asthma," said Bill McLin , President and CEO of AAFA. "Our goal is to encourage patients with asthma and their caregivers to be their own advocates and to gain access to much-needed tools and resources through educational platforms such as Get Smart About Asthma."

Teva Respiratory is a corporate sponsor of www.GetSmartAboutAsthma.com.

About Asthma
Asthma is a chronic (long-term) disease of inflammation of both the large and small airways of the lung, characterized by symptoms including wheezing and coughing. Asthma may cause recurring periods of wheezing (a whistling sound when you breathe), chest tightness, shortness of breath, and coughing that often occur at night or early in the morning.  Without appropriate treatment, asthma symptoms may persist and result in an asthma attack, which can lead to hospitalization and even death.

About Asthma and Allergy Foundation of America
The Asthma and Allergy Foundation of America (AAFA) is a not-for-profit organization founded in 1953 that serves as the leading patient organization for people with asthma and allergies, and the oldest asthma and allergy patient group in the world.  AAFA is dedicated to improving the quality of life for people with asthma and allergic diseases through education, advocacy and research. AAFA provides practical information, community-based services and support to people through a network of regional chapters, support groups and other local partners around the U.S. AAFA develops health education, organizes state and national advocacy efforts and funds research to find better treatments and cures.

About Teva Respiratory
Teva Respiratory is the U.S.-based respiratory subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE:   TEVA). Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in about 60 countries.


'/>"/>
SOURCE The Asthma and Allergy Foundation of America
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Growing Prevalence of Asthma is Fueling Vigorous Industry Competition for Effective, Affordable Therapies
2. Global Markets for Asthma and COPD Drugs
3. Rigel Initiates Phase 2 Clinical Studies with R343 for Asthma and R333 for Discoid Lupus
4. iSoneas AsthmaSense Smartphone App Now Free
5. Asthmapolis Expands Dignity Health Study to Include Mercy Medical Group Patients
6. Synapse Develops Technology for Innovative Asthma Management Device
7. Asthmapolis Receives FDA Clearance for Asthma Inhaler Sensor Technology and Accompanying Software System
8. Lifescript Launches New Online Asthma Health Center
9. Asthma and COPD Drug Market Expected to Reach USD 26,965.5 Million Globally in 2017: Transparency Market Research
10. COPD Tops Asthma as the Focus Indication for Next Generation Respiratory Therapies at the 2012 American Thoracic Society Conference
11. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... March 1, 2017  Numotion, the nation,s leading provider ... of Tek RMD ("robotic mobilization device") by Matia Robotics ... RMD is a motorized standing movement device that offers ... wheelchair to complete everyday activities from a standing position. ... Tek RMD unassisted. Numotion is the exclusive distributor of ...
(Date:3/1/2017)... ... Research and Markets has announced the addition of the "Global ... The Global Infertility Therapy Partnering Terms and Agreements since ... entered into by the world,s leading healthcare companies. The ... are discovery or development stage whereby the licensee obtains a right ...
(Date:3/1/2017)... PRINCETON, N.J. , March 1, ... Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun ... today announced that several new analyses from Phase-1 ... and 2) of tildrakizumab, an investigational IL-23p19 inhibitor ... psoriasis, will be presented at the 2017 Annual ...
Breaking Medicine Technology:
(Date:3/1/2017)... ... ... After a long period of indulging in holidays, many individuals feel ready ... the detox categories, there is a rare yet successful way to cleanse the lungs ... Detox is an herbal-based formula designed to help cleanse people’s lungs from harmful chemicals ...
(Date:3/1/2017)... , ... March 01, 2017 , ... The Industrial Designers ... 5, 2017 by raising awareness of the profession of industrial design (ID) and relaunching ... content geared toward high school students and counselors; parents; and the greater public. , ...
(Date:3/1/2017)... ... March 01, 2017 , ... ... the release of its 2017 update to Compass, the popular online learning ... advisors. , Suitable for standardizing both new-hire on-boarding and annual competency-validation, Compass ...
(Date:3/1/2017)... ... 2017 , ... Grund® America is proud to announce the new ... March 2017 International Housewares Show in Chicago (Grund Booth N6466). , “We are very ... quality,100% OEKO-TEX and GOTS Organic Cotton material. By adding the GOTS (Global Organic ...
(Date:3/1/2017)... ... March 01, 2017 , ... Granite ... colorectal cancer screening rates by supporting the 80% by 2018 initiative, led by ... and the National Colorectal Cancer Roundtable (an organization co-founded by ACS and CDC). ...
Breaking Medicine News(10 mins):